Clinical Investigations and Precision Therapeutics Research Program

Program Leaders: Shridar Ganesan, MD, PhD and Janice M. Mehnert, MD

Overall Goals:

The Clinical Investigations and Precision Therapeutics Program is structured to encourage and promote maximum scientific interactions among clinical, population and laboratory investigators, and provides a platform to facilitate rapid movement of laboratory discoveries into clinical trials.

Specific Aims:

  • Develop pre-clinical therapeutic strategies and models that advance the prevention, diagnosis and treatment of cancer
    • Drug Discovery and Delivery
    • Imaging and Biomarker Development
  • Promote the translation of scientific discoveries into early phase clinical trial development
    • Cancer Metabolism and Growth
    • Genomic Instability and Cancer Genomics
    • Tumor Immunology
    • Targeted Therapeutics
  • Expand precision medicine to drive basic, translational and clinical science

Useful Links:



precision medicine at Rutgers Cancer Institute




Donate Now








Proud member of
Big Ten Cancer Research Consortium



Rutgers Health